Biden’s Drug Czar Wants To Make It Easier To Research Marijuana, Psychedelics And Other Schedule I Substances
Take notes Health Canada…
The Office of National Drug Control Policy (ONDCP) wants to simplify the registration process for researchers to access Schedule I drugs like psilocybin to be on par with Schedule II substances, as stated in a letter to congressional leaders.
The new registration process would skip some of the “lengthy and cumbersome” steps to encourage research into Schedule I substances. Applicants would only need to provide a general research proposal, information on storage and security of the substance, and qualifications to conduct the research.